Recent news on Irbesartan

Irbesartan/Hydrochlorothiazide Fixed Combination Helps Older ...  -  May 23, 2007
DG NewsThe INCLUSIVE trial found that irbesartan/HCTZ fixed-dose combination therapy is safe in more than 75% of participants whose systolic blood pressure was

Sanofi-Aventis gets SFDA's nod for new treatment indication of ...  -  May 18, 2007
Interfax.cn (subscription),SFDA approved irbesartan, an angiotensin II receptor antagonist, marketed under the trademark Aprovel, for use in treating renal disease in type 2 diabetic

Bristol-Myers Squibb Company Reports First Quarter 2007 Financial ...  -  26 Apr 2007
PR Newswire (press release),AVALIDE(R), a fixed-dose combination of irbesartan and hydrochlorothiazide, is currently approved for the treatment of hypertension, for hypertensive

FDA panel favors first-line use of irbesartan/HCTZ combo  -  Apr 19, 2007
TheHeart.Org,Rockville, MD - The US FDA Cardiovascular and Renal Drugs Advisory Committee recommended extended use of the combination product irbesartan plus

FDA Reviewer Backs Bristol's Avalide  -  Apr 16, 2007
Wall Street Journal (subscription),However, the same review said treatment with irbesartan was also effective at lowering blood pressure in many patients. The review said patients receiving

Panel backs new use of Bristol hypertension drug  -  Apr 18, 2007
ReutersAvalide, co-marketed by Sanofi-Aventis, was approved in 1997 and is cleared to treat hypertension after either of the drugs irbesartan or

US panel backs new use of Bristol hypertension drug  -  Apr 18, 2007
ReutersN: Quote, Profile, Research), was approved in 1997 and is cleared to treat hypertension after either of the drugs irbesartan or hydrochlorothiazide fails to

UPDATE 2-US FDA staffer supports new use for Bristol drug  -  Apr 16, 2007
ReutersN: Quote, Profile, Research), was first approved in 1997 and is already cleared to treat hypertension after use of either irbesartan or hydrochlorothiazide

UPDATE 1-US FDA staffer supports new use for Bristol drug  -  Apr 16, 2007
ReutersThe drug, first approved in 1997, is already approved to treat hypertension after use of either irbesartan or hydrochlorothiazide fails to help reach

FDA staffer supports new use for Bristol drug  -  Apr 16, 2007
Therapeutics Daily (subscription) (press release),The drug, co-marketed by Sanofi-Aventis, was first approved in 1997 and is already cleared to treat hypertension after use of either irbesartan or

Avalide Might Get New Use  -  Apr 18, 2007
TheStreet.comThey both contain the ingredient irbesartan. Avalide also contains a diuretic, hydrochlorothiazide, which helps guard against fluid retention.

US FDA reviewer supports new use for Bristol drug  -  Apr 16, 2007
ReutersThe drug, known generically as irbesartan/hydrochlorothiazide, is already approved to treat hypertension but not as an initial treatment.

Li et these are sickness jury channels.  -  Apr 11, 2007
Journal lycéen,Clinicians should of the when attending Avapro for picking ing the body. Too many percent as the data avapro tablet irbesartan studies on features.

Pharmacopeia tout 2-for-1 cardiovascular drug  -  Feb 19, 2007
DrugResearcher.com,Bristol-Myers Squibb and Sanofi-aventis jointly market blockbuster drug Avapro (irbesartan), which is an AII receptor blocker with combined sales last year

Pipeline match for possible Bristol-Myers Squibb and Sanofi ...  -  Jan 31, 2007
In-PharmaTechnologist.com,However, Sanofi and BMS already work closely together because they jointly market hypertension drug Avapro (irbesartan) and Plavix (clopidogrel),

Sanofi-aventis 2006: In a Difficult Environment, Another Year of ...  -  Feb 12, 2007
PR Newswire (press release),Squibb on Plavix(R)/Iscover(R) (clopidogrel) and Aprovel(R)/Avapro(R)/Karvea(R) (irbesartan) and Fujisawa on Stilnox(R)/Myslee(R) (zolpidem).

Research and Markets: 2006 Market Research Available On Bristol ...  -  18 Jan 2007
PharmaLive.com (press release),Similarly, Avapro/Avalide (irbesartan), an angiotensin II receptor agonist indicated for the treatment of hypertension and diabetic neuropathy,

Karakatsanis Bicarb Inquiry Deferred  -  Dec 18, 2006
Racing and Sports Pty Ltd,Karakatsanis was suspedned for six months in 2003 after the prohibited substance Irbesartan was found in one of his horses. News Talk is designed for debate

Research and Markets: 2006 Market Research Available On Bristol ...  -  Dec 21, 2006
PharmaLive.com (press release),Similarly, Avapro/Avalide (irbesartan), an angiotensin II receptor agonist indicated for the treatment of hypertension and diabetic neuropathy,

Highlights from EASD 2006: Targeting CV risks in dysglycemic ...  Oct 12, 2006
In patients with type 2 diabetes the angiotensin-receptor blockers (ARBs) irbesartan (the IDNT study) and losartan (the RENAAL study) prevented progression of ... -TheHeart.Org, Publicado: Sab Oct 14, 2006 5:01 pm Asunto: Unless directed to do ...  Oct 14, 2006
In ipratropium bromide ddition, red dyes w. ere removed. His favorite Pop-Tarts w ipv re the cherry ones, so that was really a double-wh irbesartan mmy. ... -Shell Security, Stroke prevention in patients with non-valvular atrial ...  Oct 14, 2006
The ACTIVE-W ( Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events ) study has shown that Warfarin is superior to platelet ... -Xagena.it, European Commission Grants Approval for Adding High Dose CoAprovel ...  Sep 18, 2006
The new CoAPROVELâ„¢ / KARVEZIDEâ„¢ 300/25 tablet, based on 300 mg of the angiotensin-II receptor blocker (ARB) irbesartan and 25 mg of the diuretic ... -PharmaLive.com

EUROPEAN COMMISSION GRANTS APPROVAL FOR ADDING HIGH DOSE COAPROVEL ...  Sep 5, 2006
The new CoAPROVEL(TM) / KARVEZIDE(TM) 300/25 tablet, based on 300 mg of the angiotensin-II receptor blocker (ARB) irbesartan and 25 mg of the diuretic ... -ITNews

Oral Anticoagulation for Stroke Prevention in AF  Sep 20, 2006
Clopidogrel Plus Aspirin versus Oral Anticoagulation for Atrial Fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of ... -Therapeutics Daily (subscription)

New analysis from ACTIVE-W fuels debate over aspirin use with ACE ...  Sep 13, 2006
Meeting, Dr Akshay S Desai (Brigham and Women's Hospital, Boston, MA) noted that the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of ... -TheHeart.Org

(PRN) - IDEXX Laboratories to Present at Bear Stearns Healthcare ...  Sep 5, 2006
...[+]. (PRN) - European Commission Grants Approval for Adding High Dose CoAPROVEL(TM) / KARVEZIDE(TM) Tablet 300/25 to the Irbesartan Hypertension Therapy Range ... -Bolsamania.com

The Committee gave positive opinions for applications for ...  -  Nov 21, 2006
Easy Bourse (Communiqués de presse),Irbesartan Hydrochlorothiazide Winthrop (irbesartan/hydrochloride), from Sanofi Pharma Bristol-Myers Squibb SNC, is recommended for the treatment of

Committee for Medicinal Products for Human Use Summary of Positive ...  -  Nov 17, 2006
PharmaLive.com (press release),This fixed dose combination is indicated in patiens whose blood pressure is not adequately controlled on Irbesartan or Hydrochlorothiazide alone".

Committee for Medicinal Products for Human Use Summary of Positive ...  -  Nov 17, 2006
PharmaLive.com (press release),The active substance of Ibersartan Winthrop is irbesartan, an Angiotensin II antagonists, plain, medicinal product (C09CA04). Irbesartan is a selective

Committee for Medicinal Products for Human Use Summary of Positive ...  -  Nov 17, 2006
PharmaLive.com (press release),Irbesartan is a selective angiotensin-II receptor (type AT 1) antagonist and it is expected to block all actions of angiotensin-II mediated by the AT1

I-PRESERVE) Trial -- Study Population Compared With "Real Life ...  -  Nov 14, 2006
Medscape (subscription)The largest ongoing trial in heart failure with preserved LV systolic function is the Irbesartan in Heart Failure with Preserved Systolic Function

Dainippon Sumitomo Pharma Enters into Partnership Agreement on ...  Aug 1, 2006
Under the agreement terms, BMKK will sublicense to DSP the development, manufacturing/marketing and marketing rights of irbesartan, an anti-hypertension drug. ... -Therapeutics Daily (subscription)

Partnership Agreements Concerning Anti-Hypertension & ...  Jul 26, 2006
1. BMKK has sublicensed to DSP its domestic Japanese development, manufacturing/marketing and marketing rights of “irbesartan� (generic name), an anti ... -PipelineReview.com

Research and Markets: Plavix (Clopidogrel) Continues to be the ...  Aug 11, 2006
Similarly, Avapro/Avalide (irbesartan), an angiotensin II receptor agonist indicated for the treatment of hypertension and diabetic neuropathy, was co ... -PharmaLive.com

New research from Greece, Japan and Israel in the area of heart ...  Jul 27, 2006
Study 1: Therapy with irbesartan improves overall left ventricular function of patients with first inferior acute myocardial infarction. ... -Therapeutics Daily (subscription)

Updating European Guidelines for the Management of Hypertension  Jul 17, 2006
Recent evidence comes from a retrospective analysis of the incidence of congestive heart failure (CHF) in the patients in the Irbesartan Diabetic Nephropathy ... -Medscape (subscription)



Diabetes And Kidney  May 9, 2006
...inhibitors (ACE inhibitors such as enalapril, ramipril, lisinopril, etc.) or angiotensin receptor blockers (ARBS such as losartan, irbesartan, telmisartan, etc ... - Newindpress (subscription)

Sanofi-aventis First Quarter of 2006: Sales growth of 9.6% on a ...  May 4, 2006
...in our consolidated net sales (with Bristol-Myers Squibb on Plavix(R)/Iscover(R) (clopidogrel) and Aprovel(R)/Avapro(R)/ Karvea(R) (irbesartan), and with ... - PR Newswire





Washington DC North  Mar 17, 2006
17 of the Best Pharmaceuticals for Children Act (BPCA), on adverse event reports possibly related to clofarabine (CLOLAR), irbesartan (AVAPRO), sibutramine ... - FDA.gov



Do Lackluster Trial Findings Mean New Avenues Are Needed for Heart ...  Feb 9, 2006
The finding that an anticoagulation regimen of clopidogrel and irbesartan for the prevention of vascular events was inferior to using warfarin, the standard ... - Journal of American Medical Association (subscription),

Novartis New Phase III Data With SPP100 (aliskiren, Rasilez) ...  Jan 19, 2006
...efficacy of SPP100 in co-administration with the ACE-inhibitor (ramipril), the diuretic (hydrochlorothiazide - HCTZ) and the ARB (irbesartan), in hypertensive ... - Biotech Intelligence

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional